Apogem reaches over halfway to $1.3bn target for latest secondaries flagship
The New York Life subsidiary has raised more capital for its latest secondaries flagship than it did for the predecessor fund, according to regulatory filings.
20 February 2025•2 mins read
SECONDARIES INVESTOR
Register to unlock this content
Daily global secondaries market news and intelligence- Curated insights to keep you ahead of GP-led and LP-led secondaries
- Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
- Access to proprietary research and reports
- Selected fund performance and investor activity data